Clinical Trial Update: Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001) [Phase 2]

View source ↗

Summary

Phase II trial evaluating neoadjuvant paclitaxel poliglumex with cisplatin and radiation for esophageal cancer has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Paclitaxel poliglumex (paclitaxel poliglumex)
• Radiation therapy

Snippet

Sponsor: Brown University | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-22